Overview

A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers

Status:
Completed
Trial end date:
2019-08-23
Target enrollment:
Participant gender:
Summary
This is a first in human study to determine the safety, tolerability, pharmacokinetics and pharmacodynamics of ONO-7684 in healthy adult volunteers. This study will be conducted in 2 parts: Part A is a single-ascending dose and Part B is a multiple-ascending dose.
Phase:
Phase 1
Details
Lead Sponsor:
Ono Pharmaceutical Co. Ltd